Haleon US sales rise as company markets GLP-1 side-effect remedies
The consumer health firm is positioning products for nausea and other gastrointestinal effects common among GLP-1 users.
TR
By Tom Reyes · Markets Editor
Sep 16 11:43 ETSource: Seeking Alpha
The wire
- 01Haleon reported rising US sales, with coverage tying growth to products addressing GLP-1 side effects.
- 02Shows consumer health companies monetizing the GLP-1 boom's downstream effects.
- 03The size of the GLP-1-linked contribution to sales was not specified.
From the source
Read at news.google.comHaleon takes advantage of GLP-1 side effects as US sales rise (HLN:NYSE)